HOOK
$9.38
Hookipa Pharma
$.05
.54%
HOOK
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  ($0.52)
Revenue:  $5.14 Mil
Wednesday
Aug 11
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when HOOK reports earnings?
Beat
Meet
Miss

Where is HOOK's stock price going from here?
Up
Flat
Down
Stock chart of HOOK
Analysts
Summary of analysts' recommendations for HOOK
Score
Grade
Pivots
Resistance
$10.03
$9.83
$9.61

$9.41

Support
$9.19
$8.99
$8.77
Tweet
Growth
Description
HOOKIPA Pharma Inc. is a clinical stage biopharmaceutical company. It is engaged in developing a class of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary arenavirus platform which is designed to reprogram the body's immune system. HOOKIPA Pharma Inc. is based in New York, United States.